Jin Yang Pharmaceutical Co. Ltd (007370) — Net Asset Quality Index
Jin Yang Pharmaceutical Co. Ltd (007370) has a Net Asset Quality Index of 58.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩271.49 Billion minus total liabilities of ₩111.51 Billion yields net assets of ₩159.98 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Jin Yang Pharmaceutical Co. Ltd (007370) liquidity interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jin Yang Pharmaceutical Co. Ltd Net Asset Quality Index Over Time (2014–2025)
This chart shows how Jin Yang Pharmaceutical Co. Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the index stands at 58.9%, representing net assets of ₩159.98 Billion against total assets of ₩271.49 Billion KRW. Explore 007370 cash flow metrics to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Jin Yang Pharmaceutical Co. Ltd (2014–2025)
The table below presents the year-by-year Net Asset Quality Index for Jin Yang Pharmaceutical Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Jin Yang Pharmaceutical Co. Ltd.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 59.7% | ₩159.86 Billion | ₩267.81 Billion | ₩107.95 Billion | ▲ +7.0 pp |
| 2024 | 52.7% | ₩119.88 Billion | ₩227.57 Billion | ₩107.70 Billion | ▼ -22.0 pp |
| 2023 | 74.7% | ₩89.58 Billion | ₩119.91 Billion | ₩30.32 Billion | ▲ +6.9 pp |
| 2022 | 67.8% | ₩77.58 Billion | ₩114.44 Billion | ₩36.87 Billion | ▲ +1.5 pp |
| 2021 | 66.3% | ₩65.32 Billion | ₩98.50 Billion | ₩33.18 Billion | ▼ -1.7 pp |
| 2020 | 68.0% | ₩46.31 Billion | ₩68.08 Billion | ₩21.77 Billion | ▲ +4.1 pp |
| 2019 | 64.0% | ₩43.67 Billion | ₩68.28 Billion | ₩24.61 Billion | ▲ +3.9 pp |
| 2018 | 60.0% | ₩42.05 Billion | ₩70.06 Billion | ₩28.01 Billion | ▲ +2.6 pp |
| 2017 | 57.4% | ₩42.38 Billion | ₩73.85 Billion | ₩31.47 Billion | ▼ -6.6 pp |
| 2016 | 64.0% | ₩49.15 Billion | ₩76.78 Billion | ₩27.64 Billion | ▼ -4.1 pp |
| 2015 | 68.1% | ₩59.18 Billion | ₩86.90 Billion | ₩27.72 Billion | ▼ -12.1 pp |
| 2014 | 80.2% | ₩61.48 Billion | ₩76.68 Billion | ₩15.20 Billion | — |